GT Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GT Biopharma and other ETFs, options, and stocks.

About GTBP

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). 

CEO
Michael Breen
CEOMichael Breen
Employees
1
Employees1
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
1965
Founded1965
Employees
1
Employees1

GTBP Key Statistics

Market cap
5.79M
Market cap5.79M
Price-Earnings ratio
-0.32
Price-Earnings ratio-0.32
Dividend yield
—
Dividend yield—
Average volume
8.53K
Average volume8.53K
High today
$2.35
High today$2.35
Low today
$2.28
Low today$2.28
Open price
$2.30
Open price$2.30
Volume
10.90K
Volume10.90K
52 Week high
$10.66
52 Week high$10.66
52 Week low
$1.72
52 Week low$1.72
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.